Miahelsa Holdings Corporation AI Stock Analysis
Want to see JP:7129 full AI Analyst Report?
Miahelsa Holdings Corporation (7129) AI Stock Analysis
Miahelsa Holdings Corporation
(TSE/TYO:7129)
The score is held back primarily by weak financial quality: despite reliable revenue growth, improving operating margins, and dependable operating cash flow, net profitability is extremely thin and inconsistent, and the projected FY2026 jump in total debt to ¥5.86B reverses recent deleveraging progress and threatens bottom-line results. Technicals add little support, with the stock trading below all key moving averages and a negative MACD pointing to soft momentum. The main offset is valuation, where a moderate 15.1x P/E and a 2.69% dividend yield provide some cushion. Overall, this is a stable-demand but capital-intensive business whose leverage and margin volatility limit its attractiveness.
Miahelsa Holdings Corporation (7129) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.16B
- Dividend Yield
- 2.69%
- Average Volume (3M)
- 2,760
- Price to Earnings (P/E)
- 15.1
- Beta (1Y)
- 0.11
- Revenue Growth
- 4.13%
- EPS Growth
- -38.70%
- Country
- Japan
- Employees
- 1,838
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Miahelsa Holdings Corporation Business Overview & Revenue Model
Company Description
Miahelsa Holdings Corporation, based in Tokyo, Japan, operates a diverse portfolio of services primarily encompassing the pharmaceutical, childcare, and elder care sectors. In its pharmaceutical segment, the company manages dispensing pharmacies and...
Miahelsa Holdings Corporation Financial Statement Overview
Summary
Miahelsa Holdings delivers steady revenue growth (¥19.5B in FY2022 to ¥23.8B in FY2025, with ~3.2% growth projected for FY2026) and improving operating profit (EBIT up from ¥186M to ¥641M), supported by consistently positive operating cash flow of ¥0.9–1.6B that comfortably exceeds reported earnings. However, net margins are razor-thin and volatile (0.02% in FY2024 vs 1.3% in FY2025), and FY2026 net income is projected to fall to ¥201M despite higher revenue. The balance sheet is the weakest link: after deleveraging from 1.64x to 0.89x debt-to-equity, total debt is projected to surge to ¥5.86B in FY2026, pushing leverage back toward ~1.5x and reintroducing meaningful risk. Equity remains only ~25–29% of assets and ROE is erratic.
Income Statement
52NeutralBalance Sheet
40NegativeCash Flow
58Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.11B | 24.85B | 23.83B | 22.72B | 22.25B | 19.51B |
| Gross Profit | 2.69B | 2.67B | 2.39B | 2.16B | 2.01B | 1.90B |
| EBITDA | 1.38B | 1.07B | 1.15B | 748.69M | 1.03B | 1.09B |
| Net Income | 177.63M | 200.85M | 299.87M | 5.53M | 209.58M | 291.57M |
Balance Sheet | ||||||
| Total Assets | 13.17B | 15.59B | 13.28B | 13.81B | 14.14B | 14.21B |
| Cash, Cash Equivalents and Short-Term Investments | 2.98B | 4.52B | 1.63B | 1.90B | 1.27B | 1.12B |
| Total Debt | 2.94B | 5.86B | 3.37B | 4.41B | 4.98B | 5.25B |
| Total Liabilities | 9.28B | 11.68B | 9.48B | 10.50B | 10.80B | 11.00B |
| Stockholders Equity | 3.89B | 3.91B | 3.79B | 3.31B | 3.34B | 3.20B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 513.78M | 500.49M | 1.29B | 481.99M | -3.21M |
| Operating Cash Flow | 0 | 905.96M | 1.01B | 1.59B | 1.02B | 918.91M |
| Investing Cash Flow | 0 | -363.87M | -455.50M | -336.08M | -556.76M | -2.53B |
| Financing Cash Flow | 0 | 2.41B | -853.40M | -610.32M | -368.67M | 2.01B |
Miahelsa Holdings Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7129, the sentiment is Negative. The current price of 1119.00 is below the 20-day moving average (MA) of 1124.30, below the 50-day MA of 1135.18, and below the 200-day MA of 1133.54, indicating a bearish trend. The MACD of -1.35 indicates Positive momentum. The RSI at 46.58 is Neutral, neither overbought nor oversold. The STOCH value of 31.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7129.
Miahelsa Holdings Corporation Peers Comparison
Overall Rating
JP:606273Outperform
JP:922069.75Neutral
JP:237357Neutral
JP:242555Neutral
JP:712952Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 73Outperform | JPY 64.01B | 14.43 | ― | 2.19% | 5.50% | 45.42% | |
| 70Neutral | JPY 3.08B | 6.39 | ― | 3.40% | 5.71% | 10.34% | |
| 57Neutral | JPY 5.21B | 18.02 | ― | 4.46% | 4.76% | -52.55% | |
| 55Neutral | JPY 2.50B | 28.45 | ― | 3.34% | -3.64% | -66.52% | |
| 52Neutral | JPY 3.13B | 15.06 | ― | 2.69% | 4.13% | -38.70% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7129 | Miahelsa Holdings Corporation | 1119.00 | 20.62 | 1.88% | |
| JP:2373 | Care Twentyone Corporation | 385.00 | -50.94 | -11.69% | |
| JP:2425 | Care Service Co., Ltd. | 658.00 | -115.78 | -14.96% | |
| JP:6062 | Charm Care Corporation | 1964.00 | 727.36 | 58.82% | |
| JP:9220 | FB CARE SERVICE CO.,LTD. | 1237.00 | 39.07 | 3.26% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
